UPCOMING EVENT
EASL 2025
Amsterdam | 7-10 May, 2025
HistoIndex Breakfast Meeting
7 May 2025 | 8 - 9:30AM CET | Amsterdam, The Netherlands
Each year the HistoIndex Breakfast Meeting event creates a unique space for impactful discussions – and 2025 will be no different.
We are looking forward to hosting another memorable scientific meeting over breakfast during EASL 2025 with our global community.
EASL Congress
7-10 May 2025
HistoIndex is proud to return to EASL 2025 with 11 accepted abstracts: 2 oral presentations & 9 posters
ORAL PRESENTATIONS
Alignment of response assessed by non-invasive fibrosis biomarkers and HistoIndex AI-based qFibrosis histology in metabolic dysfunction associated steatohepatitis (MASH) clinical trials: a new roadmap for robust drug efficacy assessment demonstrated in the HARMONY trial
Presenter: Quentin M. Anstee
OS-096 | 10:30AM – 10:45AM | Saturday, 10 May
MASLD: Clinical and therapeutical aspects II
Benhamou Room
Comparative analysis and cross-validation of Artificial Intelligence digital pathology (PathAI AIM-MASH and HistoIndex qFIB) vs. expert hepatopathologist scoring in MASLD biopsies – Results of the LITMUS Study Cohort
Presenter: Alasdair Blain
OS-095 | 10:15AM – 10:30AM | Saturday, 10 May
MASLD: Clinical and therapeutical aspects II
Benhamou Room
POSTERS
Artificial intelligence-driven qFibrosis® in alpha-1-antitrypsin deficiency-associated liver disease: correlation with METAVIR and other disease specific features
Presenter: Kay Washington
WED-342 | Wednesday, 7 May
Rare Liver Diseases (including paediatric and genetic) – Basic
Utilizing AI digital pathology for quantitative measurement, grading and differentiation of lobular and portal inflammation in MASH: preliminary analysis in liver histology
Presenter: Kutbuddin Akbary
WED-374 | Wednesday, 7 May
MASLD: Diagnostics and non-invasive assessment
Fibroblast Activity (PRO-C3) and Liver Stiffness Correlate with spatial distribution of Collagens in MASLD and ALD: Insights from Digital Pathology
Presenter: Diana Julie Leeming
WED-404 | Wednesday, 7 May
Poster – MASLD: Diagnostics and non-invasive assessment
Subgroup definition and monitoring of liver fibrosis evolution in patients with MASH bridging fibrosis based on objective measurements of septa parameters using digital pathology with artificial intelligence analyses
Presenter: Nikolai Naoumov
THU-445| Thursday, 8 May
Poster – MASLD: Clinical aspects except therapy
qFibrosis enables earlier detection of fibrosis response in Efruxifermin-treated patients with F2-F3 MASH in 96-week HARMONY study
Presenter: Jörn M. Schattenberg
TOP-458 | Saturday, 10 May
Poster – MASLD: Therapy
Characterization and validation of regional variation in fibrosis within traditional fibrosis stages
Presenter: Elaine Chng
THU-400 | Thursday, 8 May
Poster- MASLD: Clinical aspects except therapy
Ongoing fibrosis quantification in paired liver biopsy samples from MAFLD patients using AI-based digital pathology: an international multicenter study
Presenter: Ming-hua Zheng
THU-475 | Thursday, 8 May
Poster -MASLD: Clinical aspects except therapy
Steatosis in cirrhosis: A prognostic marker for liver related outcomes in Metabolic-Dysfunction Associated Steatotic Liver Disease
Presenter: Yiying Pei
THU-449-YI | Thursday, 8 May
Poster – MASLD: Clinical aspects except therapy
Denifanstat improves multiple qFibrosis-based collagen features linked to major adverse liver outcomes in patients with metabolic dysfunction-associated steatohepatitis patients and high polygenic risk
Presenter: Mary E. Rinella
SAT-437 | Saturday, 10 May
Poster – MASLD: Therapy
Get the latest updates about our events
